Company · Ownership research

ARS Pharmaceuticals, Inc. SPRY

CIK 0001671858

Form 4 transactions dated Nov 1, 2023 to Nov 11, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 48 rows; the complete set is available through the API.

Insider filings on file run through Nov 4, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $13.29M
Sold: $117.81M

Nov 1, 2023 – Nov 4, 2026
Available records · partial months are marked ·

Insiders in this window

202510 of 19 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 13, 2025	Dorsey Brian Chief Operating Officer	Sale	$190.05K 21,828 shares sold	66.92% sold Direct holding	▾
Nov 12, 2025	Chakma Justin Chief Business Officer	Sale	$1.48M 166,380 shares sold	100.00% sold Direct holding	▾
Aug 21, 2025	Lowenthal Richard E PRESIDENT AND CEO · Director · 10% owner	Sale10b5-1 footnote	$724.35K 50,000 shares sold	4.01% sold Trust holding	▾
Aug 21, 2025	Scott Kathleen D. Chief Financial Officer	Sale10b5-1 footnote	$187.50K 12,500 shares sold	55.45% sold Direct holding	▾
Aug 20, 2025	Tanimoto Sarina CHIEF MEDICAL OFFICER · 10% owner	Sale10b5-1 footnote	$530.63K 37,656 shares sold	2.93% sold Trust holding	▾
Aug 19, 2025	Tanimoto Sarina CHIEF MEDICAL OFFICER · 10% owner	Sale10b5-1 footnote	$173.13K 12,344 shares sold	0.95% sold Trust holding	▾
Jul 1, 2025	Karas Eric Chief Commercial Officer	Sale10b5-1 footnote	$254.86K 15,000 shares sold	59.25% sold Direct holding	▾
Jun 27, 2025	DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · Flynn James E · Deerfield Private Design Fund III, L.P. · Deerfield Mgmt III, L.P. · Deerfield Private Design Fund IV, L.P. · Deerfield Mgmt IV, L.P. 10% owner	Sale	$6.83M 370,075 shares sold	Unavailable Indirect holding	▾
Jun 27, 2025	DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · Flynn James E · Deerfield Private Design Fund III, L.P. · Deerfield Mgmt III, L.P. · Deerfield Private Design Fund IV, L.P. · Deerfield Mgmt IV, L.P. 10% owner	Sale	$6.83M 370,074 shares sold	Unavailable Indirect holding	▾
Jun 18, 2025	Karas Eric Chief Commercial Officer	Sale10b5-1 footnote	$240.00K 15,000 shares sold	66.09% sold Direct holding	▾

Showing 19 / 19 record groups in 2025. The complete set is available through the API.

ARS Pharmaceuticals, Inc. · SPRY

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 19 of 19 purchase / sale groups and 30 of 48 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"SPRY","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.